Skip to main content

Update on FDA's Inactive Ingredient Database

Presentation Icon
The FDA's IID is used in drug development decisions by industry and application assessment decisions by FDA. In the year 2020 the IID changed. How will these changes affect excipient suppliers and drug product applicants? Find out what's changing in 2022 and how you can be prepared.

Track: Quality & Regulatory

Presentation Level: Fundamental (requires little or no previous knowledge of the topic)

Target Audience by Industry Segment:
> Pharmaceutical - Generic Drugs
> Pharmaceutical - Originator Drugs
> Biologics - Biotech Drugs (Originators)
> Biologics - Biosimilars (Follow on Biologics)

Target Audience by Role:
> Formulations
> Research & Development
> Regulatory

Note: Presentations are available for on-demand viewing for 21 days after purchase.
More Items for Purchase in this Course